About 49,550 results

ALLMedicine™ Pancreatic Cancer Center

Research & Reviews  15,189 results

Can combined use of tumor markers in pancreatic cancer be a solution to short- and long...
Medicine Esen E, Aslan M et. al.

Mar 18th, 2023 - As in other types of cancer, tumor markers are used in pancreatic ductal adenocarcinoma (PDAC) for disease follow-up, especially after surgery. There has been shown to be a significant correlation between the tumor marker levels and poor prognosis...

Imaging DNA damage response by γH2AX in vivo predicts treatment response to Lutetium-17...
Theranostics O'Neill E, Mosley M et. al.

Mar 17th, 2023 - Rationale: An effective absorbed dose response relationship is yet to be established for Lutetium-177 based radionuclide therapies such as 177Lu-DOTATATE and 177Lu-PSMA. The inherent biological heterogeneity of neuroendocrine and prostate cancers ...

Serum CA724 has no diagnostic value for gastrointestinal tumors.
Clinical and Experimental Medicine; Cao H, Zhu L et. al.

Mar 16th, 2023 - This study aimed to explore the predictive values of serum carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 199, CA125 and CA724 in the diagnosis of gastrointestinal tumors. Among patients treated for gastrointestinal tumors at the First ...

Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society...
International Journal of Clinical Oncology; Okusaka T, Nakamura M et. al.

Mar 16th, 2023 - Clinical Practice Guidelines for Pancreatic Cancer was first published in 2006 by the Japan Pancreas Society, and revised in 2009, 2013, 2016, and 2019. In July 2022, Clinical Practice Guidelines for Pancreatic Cancer was newly revised in Japanese...

Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors.
Journal of Controlled Release : Official Journal of the C... Anthiya S, Öztürk SC et. al.

Mar 16th, 2023 - K-RAS is a highly relevant oncogene that is mutated in approximately 90% of pancreatic cancers and 20-25% of lung adenocarcinomas. The aim of this work was to develop a new anti-KRAS siRNA therapeutic strategy through the engineering of functional...

see more →

Guidelines  27 results

ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptib...
Gastrointestinal Endoscopy; Sawhney MS, Calderwood AH et. al.

Feb 21st, 2022 - ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations.|2022|Sawhney MS,Calderwood AH,Thosani NC,Rebbeck TR,Wani S,|diagnosis,genetics,

American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic c...
Gastrointestinal Endoscopy; Calderwood AH, Sawhney MS et. al.

Feb 21st, 2022 - American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence.|2022|Calderwood AH,Sawhney MS,Thosani NC,Rebbeck TR,Wani S,|diagnosis,gene...

Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-ba...
Pancreatology : Official Journal of the International Ass...

Jun 22nd, 2021 - Pancreatic cancer is the eighth most common cancer and the fifth most common cause of cancer-related death in Korea. To enable standardization of management and facilitate improvements in outcome, a total of 53 multi-disciplinary experts in gastro...

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JN... Tempero MA, Malafa MP et. al.

Apr 13th, 2021 - Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provi...

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020).
Clinical & Translational Oncology : Official Publication ... Gómez-España MA, Montes AF et. al.

Mar 5th, 2021 - Pancreatic cancer (PC) and biliary tract cancer (BTC) are both aggressive and highly fatal malignancies. Nowadays we have a profound knowledge about the molecular landscape of these neoplasms and this has allowed new therapeutic options. Surgery i...

see more →

Drugs  61 results see all →

Clinicaltrials.gov  2,233 results

Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation

Mar 10th, 2023 - PRIMARY OBJECTIVE: I. To determine the efficacy of the combination of binimetinib and encorafenib as >= 2nd line of treatment for patients with metastatic pancreatic cancer with BRAF V600E mutation. SECONDARY OBJECTIVES: I. To determine in patient...

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

Mar 10th, 2023 - Study CP-MGC018-02 is a study of vobramitamab duocarmazine (MGC018) in combination with lorigerlimab. The study is designed to characterize safety, tolerability, pharmacokinetics (PK), immunogenicity, pharmacodynamics, and preliminary antitumor ac...

Intermittent Fasting for Pancreatitis

Mar 10th, 2023 - Fasting is a classic means for religious discipline, yet recently regaining favor in the medical landscape. Numerous studies have come forth, both in animals and humans outlining the benefit of intermittent fasting (IF) on various disease states a...

GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer

Mar 10th, 2023 - The purpose of this study is to evaluate the safety and clinical activity of FOLFIRINOX along with a whole cell vaccine with immune modulating doses of cyclophosphamide and nivolumab combined with Stereotactic Body Radiation Therapy (SBRT) in pati...

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

Mar 10th, 2023 - Individuals over 50 years of age who have developed new-onset diabetes mellitus (diagnosed within the past 12 months) or deteriorating diabetes will be recruited through the offices of primary care physicians and endocrinologists. Those meeting in...

see more →

News  2,233 results

Half of World Soon Overweight; FDA Rejects Severe COVID Drug; Feinstein Hospitalized

Mar 3rd, 2023 - Note that some links may require subscriptions. More than half of the world -- representing over 4 billion people -- are expected to be overweight or obese by 2035, according to the World Obesity Federation. Walgreens will not dispense the abortio...

Pancreatic cancer incidence increases among young women in U.S.
Carolyn Crist

Feb 27th, 2023 - The age-adjusted incidence rate of pancreatic cancer is increasing in young women in the United States, and it doesn’t show signs of slowing down, according to a new study published in Gastroenterology. Cedars-Sinai Medical Center Dr.

Cancer and Heart Disease; Screening During COVID; CBD for Smoking Cessation

Feb 17th, 2023 - The American Cancer Society has advice about how the more than 18 million adult cancer survivors can reduce their risk of developing heart disease. Some reassuring data about COVID and cancer screening: Missed screenings during the pandemic have n...

Faking a Cancer Dx? Fallopian Tube Removal; Trodelvy's New Breast Cancer Indication

Feb 3rd, 2023 - A 19-year-old Iowa woman has been arrested after being accused of faking diagnoses of leukemia and pancreatic cancer in order to collect more than $37,000 in online donations. (CBS News) The Ovarian Cancer Research Alliance is urging even women wi...

Watch for New Psych Disorders in the Spouses of Cancer Patients

Jan 5th, 2023 - The heightened stress of having a spouse battling cancer may manifest in a clinical diagnosis of a new psychiatric disorder, a population-based cohort study found. Looking at over 3 million people living in Denmark and Sweden, there was a higher i...

see more →

Patient Education  77 results see all →